(2012). Co-administration of statins with cytochrome P450 3A4 inhibitors in a UK primary care population. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.2308.
(2018). Serum potassium as a predictor of adverse clinical outcomes in patients with chronic kidney disease: new risk equations using the UK clinical practice research datalink. BMC Nephrol. http://doi.org/10.1186/s12882-018-1007-1.
(2019). Predicting atrial fibrillation in primary care using machine learning. PLoS One. http://doi.org/10.1371/journal.pone.0224582.
(2019). Real-World Associations of Renin-Angiotensin-Aldosterone System Inhibitor Dose, Hyperkalemia, and Adverse Clinical Outcomes in a Cohort of Patients With New-Onset Chronic Kidney Disease or Heart Failure in the United Kingdom. J Am Heart Assoc. http://doi.org/10.1161/jaha.119.012655.
(2019). Serum potassium and clinical outcomes in heart failure patients: results of risk calculations in 21 334 patients in the UK. ESC Heart Fail. http://doi.org/10.1002/ehf2.12402.
(2020). Real-world data on the incidence, mortality, and cost of ischaemic stroke and major bleeding events among non-valvular atrial fibrillation patients in England. J Eval Clin Pract. http://doi.org/10.1111/jep.13400.
(2021). Excess deaths in people with cardiovascular diseases during the COVID-19 pandemic. Eur J Prev Cardiol. http://doi.org/10.1093/eurjpc/zwaa155.